PORCIANI, MARIA CRISTINA
PORCIANI, MARIA CRISTINA
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
A major involvment of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene.
1997 G.Pepe; B.Giusti; M.Attanasio; P.Comeglio; M.C.Porciani; L.Giurlani; GF.Montesi; GC.Calamai; M.Vaccari; S.Favilli; R.Abbate; GF.Gensini
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.
2008 M.C. Porciani; C.M. Rao; M. Mochi; F. Cappelli; G. Bongiorno; A.P. Perini; A. Lilli; G. Ricciardi; L. Hashtroudi; P. Silvestri; S.S. Barold; L. Padeletti
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients
2010 L. Evangelisti; L. Lucarini; M. Attanasio; I. Lapini; B. Giusti; M.C. Porciani; G.F. Gensini; R. Abbate; G. Pepe
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops.
2012 Padeletti L1; Pieragnoli P; Ricciardi G; Perrotta L; Grifoni G; Porciani MC; Lionetti V; Valsecchi S
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients
2008 C.Fatini; M.Attanasio; C.Porciani; E.Sticchi; L.Padeletti; I.Lapini; R.Abbate; GF.Gensini; G.Pepe
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy.
2012 Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Pontecorboli G; De Santo T; Bellocci F; Vitulano N; Emdin M; Mascioli G; Ricceri I; Porciani MC; Michelucci A; Padeletti L.
Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome
2012 S.Nistri; M.C.Porciani; M.Attanasio; R.Abbate; G.F.Gensini; G.Pepe
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY.
2004 L. PADELETTI; N. MUSILLI; M. PORCIANI; A. COLELLA; G. RICCIARDI; P. PIERAGNOLI; A. MICHELUCCI; GF. GENSINI; L. DI BIASE
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements
2000 L.Padeletti; MC.Porciani; P.Ritter; A.Michelucci; A.Colella; P.Pieragnoli; A.Costoli; C.Ciapetti; A.Sabini; G.De Marchi; Gillio-Meina L; G.Gaggini; GF.Gensini
Bioavailability of digoxin-hydroquinone complex
1978 L. Padeletti; M.C. Porciani; P. Simondi; L. Bianchini; C. Arcangeli; F. Taruffi; L.M. Pernice; R. Lepore
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy.
2011 Padeletti L1; Fantappiè C; Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Valsecchi S; Porciani MC; Michelucci A; Fantini F
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.
2007 A Lilli; G. Ricciardi; M.C. Porciani; A. P. Perini; P. Pieragnoli; N. Musilli; A. Colella; S. Del Pace; A. Michelucci; F. Turreni; M. Sassara; A. Achilli; S.S. Barold; L. Padeletti
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure.
1998 MICHELUCCI A.; A. CONTI; FRATI M.; MININNI S.; PADELETTI L.; PORCIANI M.C.; GENSINI G.F.
Diastolic subclinical primary alterations in Marfan syndrome and Marfan related disorders
2002 MC.PORCIANI; L.GIURLANI; A.CHELUCCI; G. PEPE; B.GIUSTI; T.BRUNELLI; M.ATTANASIO; P.MARTINUCCI; R.FATTORI; R.ABBATE; G.F.GENSINI
Dual-site left ventricular cardiac resynchronization therapy.
2008 L. Padeletti; A. Colella; A. Michelucci; P. Pieragnoli; G. Ricciardi; M.C. Porciani; F. Tronconi; D.A. Hettrick; S. Valsecchi.
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis.
2013 Attanasio M;Pratelli E;Porciani MC;Evangelisti L;Torricelli E;Pellicanò G;Abbate R;Gensini GF;Pepe G
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure
2006 Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L.
Electrophysiologic procedures and activation of the hemostatic system
1999 A.Michelucci; E.Antonucci; AA.Conti; AA.Liotta; S.Fedi; L.Padeletti; MC.Porciani; D.Prisco; R.Abbate; GF.Gensini
Evidence for oxidative stress in plasma of patients with Marfan syndrome
2010 C. Fiorillo; M. Becatti; M. Attanasio; L. Lucarini; N. Nassi; L. Evangelisti; M.C. Porciani; P. Nassi; G.F. Gensini; R. Abbate; G. Pepe
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.
2008 M.Attanasio; I.Lapini; L.Evangelisti; L.Lucarini; B.Giusti; C.Porciani; R.Fattori; C.Anichini; R.Abbate; GF.Gensini; G.Pepe.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A major involvment of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. | 1997 | G.Pepe; B.Giusti; M.Attanasio; P.Comeglio; M.C.Porciani; L.Giurlani; GF.Montesi; GC.Calamai; M.Vaccari; S.Favilli; R.Abbate; GF.Gensini | |
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. | 2008 | M.C. Porciani; C.M. Rao; M. Mochi; F. Cappelli; G. Bongiorno; A.P. Perini; A. Lilli; G. Ricciardi; L. Hashtroudi; P. Silvestri; S.S. Barold; L. Padeletti | |
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients | 2010 | L. Evangelisti; L. Lucarini; M. Attanasio; I. Lapini; B. Giusti; M.C. Porciani; G.F. Gensini; R. Abbate; G. Pepe | |
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. | 2012 | Padeletti L1; Pieragnoli P; Ricciardi G; Perrotta L; Grifoni G; Porciani MC; Lionetti V; Valsecchi S | |
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients | 2008 | C.Fatini; M.Attanasio; C.Porciani; E.Sticchi; L.Padeletti; I.Lapini; R.Abbate; GF.Gensini; G.Pepe | |
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. | 2012 | Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Pontecorboli G; De Santo T; Bellocci F; Vitulano N; Emdin M; Mascioli G; Ricceri I; Porciani MC; Michelucci A; Padeletti L. | |
Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome | 2012 | S.Nistri; M.C.Porciani; M.Attanasio; R.Abbate; G.F.Gensini; G.Pepe | |
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. | 2004 | L. PADELETTI; N. MUSILLI; M. PORCIANI; A. COLELLA; G. RICCIARDI; P. PIERAGNOLI; A. MICHELUCCI; GF. GENSINI; L. DI BIASE | |
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements | 2000 | L.Padeletti; MC.Porciani; P.Ritter; A.Michelucci; A.Colella; P.Pieragnoli; A.Costoli; C.Ciapetti; A.Sabini; G.De Marchi; Gillio-Meina L; G.Gaggini; GF.Gensini | |
Bioavailability of digoxin-hydroquinone complex | 1978 | L. Padeletti; M.C. Porciani; P. Simondi; L. Bianchini; C. Arcangeli; F. Taruffi; L.M. Pernice; R. Lepore | |
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. | 2011 | Padeletti L1; Fantappiè C; Perrotta L; Ricciardi G; Pieragnoli P; Chiostri M; Valsecchi S; Porciani MC; Michelucci A; Fantini F | |
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. | 2007 | A Lilli; G. Ricciardi; M.C. Porciani; A. P. Perini; P. Pieragnoli; N. Musilli; A. Colella; S. Del Pace; A. Michelucci; F. Turreni; M. Sassara; A. Achilli; S.S. Barold; L. Padeletti | |
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. | 1998 | MICHELUCCI A.; A. CONTI; FRATI M.; MININNI S.; PADELETTI L.; PORCIANI M.C.; GENSINI G.F. | |
Diastolic subclinical primary alterations in Marfan syndrome and Marfan related disorders | 2002 | MC.PORCIANI; L.GIURLANI; A.CHELUCCI; G. PEPE; B.GIUSTI; T.BRUNELLI; M.ATTANASIO; P.MARTINUCCI; R.FATTORI; R.ABBATE; G.F.GENSINI | |
Dual-site left ventricular cardiac resynchronization therapy. | 2008 | L. Padeletti; A. Colella; A. Michelucci; P. Pieragnoli; G. Ricciardi; M.C. Porciani; F. Tronconi; D.A. Hettrick; S. Valsecchi. | |
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis. | 2013 | Attanasio M;Pratelli E;Porciani MC;Evangelisti L;Torricelli E;Pellicanò G;Abbate R;Gensini GF;Pepe G | |
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure | 2006 | Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L. | |
Electrophysiologic procedures and activation of the hemostatic system | 1999 | A.Michelucci; E.Antonucci; AA.Conti; AA.Liotta; S.Fedi; L.Padeletti; MC.Porciani; D.Prisco; R.Abbate; GF.Gensini | |
Evidence for oxidative stress in plasma of patients with Marfan syndrome | 2010 | C. Fiorillo; M. Becatti; M. Attanasio; L. Lucarini; N. Nassi; L. Evangelisti; M.C. Porciani; P. Nassi; G.F. Gensini; R. Abbate; G. Pepe | |
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. | 2008 | M.Attanasio; I.Lapini; L.Evangelisti; L.Lucarini; B.Giusti; C.Porciani; R.Fattori; C.Anichini; R.Abbate; GF.Gensini; G.Pepe. |